Last price paid | 3.77 | |
Change | +8.96% [ +0.31 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 11.07.2024 17:20 |
Fixing | n.a. |
Settlement date | 18.04.2024 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +26.63% |
Year to date (YTD) | n.a. |
1 month | +37.09% |
3 months | n.a. |
1 year | n.a. |
3 years | n.a. |
Issue price | 2.61 |
Underlying price on issue | 28.45 |
Premium | 0.00% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1305151966 |
Symbol | IXA08Z |
Security | 130515196 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Troy Ounce of Silver in USD, XC0009653103 |
Underlying ISIN | XC0009653103 |
Funding level | 23.240600 |
Stop-loss level | 23.411700 |
Distance to stop-loss level | 23.46% |
Long/Short type | Long |
Subscription ratio | 2.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 16.04.2024 |
Premium | 0.14% |
Premium p.a. | n.a. |
Leverage | 4.14 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 7.346100 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
NOVARTIS N | 100.50 |
ABB Ltd | 51.42 |
ROCHE GS | 254.70 |
UBS | 27.98 |
Partners Group Ho... | 1'236.00 |
Name | Price |
---|---|
KUEHNE & NAGEL | 256.50 |
Lonza Group | 516.60 |
SONOVA HLDG N | 275.20 |
Swiss Life Hldg | 675.40 |
Givaudan | 4'361.00 |